AUC Logo

Minnesota AUC Administrative Simplification
 

Prescription Drug Electronic Prior Authorization Technical Technical Advisory Group (Rx ePA TAG)

Meeting Information
(Note: No TAG meetings are scheduled at this time)

Policies

SBAR and work request forms


Co-chairs

 • Skyler Resvick  sresvic1@fairview.org  612-672-5272


Charge and mission statement of work

To create and develop Minnesota Uniform Companion Guide for prescription drug electronic prior authorization (Rx ePA) as required by Minnesota Statutes, section 62J.497, Subd. 5. The law requires that by January 1, 2014, the Minnesota Administrative Uniformity Committee shall develop the standard companion guide by which providers and group purchasers will exchange standard drug authorization requests using electronic data interchange standards, if available, with the goal of alignment with standards that are or will potentially be used nationally.

The law further requires that no later than January 1, 2015, drug prior authorization requests must be accessible and submitted by health care providers, and accepted by group purchasers, electronically through secure electronic transmissions. Facsimile shall not be considered electronic transmission.

The law further requires that no later than January 1, 2015, drug prior authorization requests must be accessible and submitted by health care providers, and accepted by group purchasers, electronically through secure electronic transmissions. Facsimile shall not be considered electronic transmission.

Scope of work

  • Develop a standard companion guide for prescription drug electronic prior authorization (Rx ePA) by January 1, 2014.

Work plan

  • Recruit representation and active participation from the pharmacy industry in the companion guide development process.
  • Develop plans and timelines to undertake the companion guide development.
  • Organize, inform, and conduct the reviews and discussion needed to develop the companion guide.

Work product to be developed

  • Recruit representation and active participation from the pharmacy industry in the companion guide development process.
  • Develop plans and timelines to undertake the companion guide development.
  • Organize, inform, and conduct the reviews and discussion needed to develop the companion guide.

Work groups: N/A

Activation or re-activation date: May 1, 2013

Inactivation date (if applicable): N/A

Back to top

 
 Most Viewed